The increasing demand for Fibroblast Growth Factors (FGFs) controlled immunological investigation and therapeutic creation has spurred significant progress in recombinant growth factor manufacture. IL-1A, IL-1B, IL-2, and IL-3, each possessing unique physiological roles, are frequently produced using various expression systems, including prokaryoti